Table 1 Patient demographics. Race and menopause status data were available for 190 women; ethnicity data were available for 191 women. P values were calculated using Kruskal-Wallis test for continuous variables and Fisher’s exact test for categorical variables
From: Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
All (n = 192) | Benign conditions (n = 108) | Endometrial hyperplasia (n = 18) | Low-grade endometrioid carcinoma (n = 53) | Other endometrial cancer subtypes (n = 13) | P value | |
|---|---|---|---|---|---|---|
Age [mean (SD)] | 51.02 (12.45) | 45.55 (10.01) | 54.11 (13.35) | 58.73 (11.82) | 60.77 (8.06) | < 0.0001 |
Race [n (%)] | ||||||
White/Caucasian | 142 (74.74) | 78 (72.90) | 16 (88.89) | 37 (71.15) | 11 (84.62) | 0.16 |
American Indian/Alaska Native | 15 (7.89) | 5 (4.67) | 1 (5.56) | 8 (15.38) | 1 (7.69) | |
Black/African American | 12 (6.32) | 11 (10.28) | 0 (0.00) | 1 (1.92) | 0 (0.00) | |
Other | 21 (11.05) | 13 (12.15) | 1 (5.56) | 6 (11.54) | 1 (7.69) | |
Ethnicity [n (%)] | ||||||
Hispanic | 50 (26.18) | 32 (29.63) | 4 (22.22) | 11 (21.15) | 3 (23.08) | 0.67 |
Non-Hispanic | 141 (73.82) | 76 (70.37) | 14 (77.78) | 41 (78.85) | 10 (76.92) | |
Body mass index [mean (SD)] | 34.76 (10.16) | 30.63 (7.54) | 41.49 (7.45) | 40.29 (11.07) | 37.22 (12.76) | < 0.0001 |
Menopause status [n (%)] | ||||||
Premenopausal | 108 (56.84) | 89 (82.41) | 6 (33.33) | 12 (23.53) | 1 (7.69) | < 0.0001 |
Postmenopausal | 82 (43.16) | 19 (17.59) | 12 (66.67) | 39 (76.47) | 12 (92.31) | |